• 0413 - 235 5879
  • drboomi@genomediscovery.org
  • No.101, 12th Cross, Rainbow Nagar, Puducherry-605 001

Molecular  therapy for Non-alcoholic fatty liver disease (NAFLD): Melatonin promotes degradation of HMGCR, decreases the levels of triglycerides, free cholesterol, and total cholesterol and prevents the progression of Non-alcoholic fatty liver disease (NAFLD via down regulation of its target gene, 24/March/2018, 12.32 am

Scroll Down

"Help us make a difference by supporting our mission with your generous donation."

FOR DONATION

Molecular  therapy for Non-alcoholic fatty liver disease (NAFLD): Melatonin promotes degradation of HMGCR, decreases the levels of triglycerides, free cholesterol, and total cholesterol and prevents the progression of Non-alcoholic fatty liver disease (NAFLD via down regulation of its target gene, 24/March/2018, 12.32 am

Spread the love
        


Spread the love
        

ABOUT OUR VISITORS

“Website without visitors is like a ship lost in the horizon.”

Page Visits --- 0
Today --- 0
Total ------ 0

"Help us make a difference by supporting our mission with your generous donation."

FOR DONATION
small_c_popup.png

Let's have a chat!

Sign-up for our newsletter to learn more about upcoming Genomediscovery Forums!